Related Experiment Video
Updated: Jul 29, 2025

Isolation and Kv Channel Recordings in Murine Atrial and Ventricular Cardiomyocytes
Published on: March 12, 2013
Genetics in Probands With Idiopathic Ventricular Fibrillation: A Multicenter Study
Luigi Pannone1, Anaïs Gauthey1, Giulio Conte2
1Heart Rhythm Management Centre, Postgraduate Program in Cardiac Electrophysiology and Pacing, Universitair Ziekenhuis Brussel-Vrije Universiteit Brussel, European Reference Networks Guard-Heart, Brussels, Belgium.
Genetic analysis in idiopathic ventricular fibrillation (IVF) reveals that carrying pathogenic or uncertain variants predicts ventricular arrhythmias (VA). Patients without variants showed better outcomes, highlighting the importance of genotype-phenotype correlation in IVF.
Area of Science:
- Cardiology
- Genetics
- Molecular Biology
Background:
- Idiopathic ventricular fibrillation (IVF) has associated genes, but genotype-phenotype correlations are lacking.
- Understanding the genetic basis of IVF is crucial for predicting clinical outcomes.
Purpose of the Study:
- To determine the genetic profile of idiopathic ventricular fibrillation (IVF) patients using comprehensive gene panel analysis.
- To correlate genetic findings with long-term clinical outcomes, specifically ventricular arrhythmias (VA).
Main Methods:
- A multicenter retrospective study included 45 consecutive IVF probands.
- Broad gene panel analysis was performed, classifying variants as pathogenic/likely pathogenic (P+), variants of unknown significance (VUS), or no variants (NO-V).
- The primary endpoint was the occurrence of ventricular arrhythmias (VA) over a mean follow-up of 105 months.
Main Results:
- A genetic variant was identified in 12 patients (3 P+, 9 VUS).
- No deaths occurred, but 35.6% of patients experienced VA.
- Patients with no variants (NO-V) had significantly higher VA-free survival compared to VUS and P+ carriers (P < 0.001 and P = 0.013, respectively).
Conclusions:
- The diagnostic yield for pathogenic/likely pathogenic (P+) variants in IVF is 6.7% using broad gene panels.
- Carrier status for P+ or VUS variants is a significant predictor of future ventricular arrhythmias (VA) in IVF patients.
More Related Videos
Related Concept Videos
Acute Coronary Syndrome III: Diagnostic Studies
Mechanism of Cardiac Arrhythmias
Cardiomyopathy I: Introduction and Classification
Electrophysiology of Normal Cardiac Rhythm
Cardiomyopathy III: Hypertrophic Cardiomyopathy
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

